# Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

> **NCT03090386** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Brain Tumor

## Interventions

- **OTHER:** Cognitive Surveys

## Key facts

- **NCT ID:** NCT03090386
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-25
- **Primary completion:** 2018-11-15
- **Final completion:** 2020-11-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090386, "Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03090386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*